Gabriele Buda

Characteristics and outcome of therapy‐related myeloid neoplasms: Report from the <scp>I</scp>talian network on secondary leukemias

Luana Fianchi, Livio Pagano, Alfonso Piciocchi et al. · American Journal of Hematology · 2015 · 121 citations · Full text

Hematological Malignancy, Shorter Latency, Therapy‐related Myeloid Neoplasms +13

[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions

Dario Genovesi, Giuseppe Vergaro, Assuero Giorgetti et al. · JACC. Cardiovascular imaging · 2020 · 108 citations

Positron Emission Tomography, Cardiomyopathy, Differential Diagnosis +9

Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study

Stefano Sacchi, Luigi Marcheselli, Alessia Bari et al. · Haematologica · 2008 · 106 citations · Full text

Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicin

Gabriele Buda, Deborah Ricci, Chuican Huang et al. · Annals of Hematology · 2010 · 60 citations · Full text

High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naïve lymphocytes and prevents TTV reactivation

Lorenzo Iovino, Francesco Mazziotta, Giovanni Carulli et al. · Leukemia Research · 2018 · 53 citations · Full text

Cell Therapy, Transplantation, Stem Cells +9